Cargando…

Exploring the Phospholipid Transport Mechanism of ATP8A1-CDC50

P4-ATPase translocates lipids from the exoplasmic to the cytosolic plasma membrane leaflet to maintain lipid asymmetry distribution in eukaryotic cells. P4-ATPase is associated with severe neurodegenerative and metabolic diseases such as neurological and motor disorders. Thus, it is important to und...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Honghui, Zhang, Yue, Xu, Peiyi, Bai, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953615/
https://www.ncbi.nlm.nih.gov/pubmed/36831082
http://dx.doi.org/10.3390/biomedicines11020546
_version_ 1784893921672822784
author Zhang, Honghui
Zhang, Yue
Xu, Peiyi
Bai, Chen
author_facet Zhang, Honghui
Zhang, Yue
Xu, Peiyi
Bai, Chen
author_sort Zhang, Honghui
collection PubMed
description P4-ATPase translocates lipids from the exoplasmic to the cytosolic plasma membrane leaflet to maintain lipid asymmetry distribution in eukaryotic cells. P4-ATPase is associated with severe neurodegenerative and metabolic diseases such as neurological and motor disorders. Thus, it is important to understand its transport mechanism. However, even with progress in X-ray diffraction and cryo-electron microscopy techniques, it is difficult to obtain the dynamic information of the phospholipid transport process in detail. There are still some problems required to be resolved: (1) when does the lipid transport happen? (2) How do the key residues on the transmembrane helices contribute to the free energy of important states? In this work, we explore the phospholipid transport mechanism using a coarse-grained model and binding free energy calculations. We obtained the free energy landscape by coupling the protein conformational changes and the phospholipid transport event, taking ATP8A1-CDC50 (the typical subtype of P4-ATPase) as the research object. According to the results, we found that the phospholipid would bind to the ATP8A1-CDC50 at the early stage when ATP8A1-CDC50 changes from E2P to E2Pi-PL state. We also found that the electrostatic effects play crucial roles in the phospholipid transport process. The information obtained from this work could help us in designing novel drugs for P-type flippase disorders.
format Online
Article
Text
id pubmed-9953615
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99536152023-02-25 Exploring the Phospholipid Transport Mechanism of ATP8A1-CDC50 Zhang, Honghui Zhang, Yue Xu, Peiyi Bai, Chen Biomedicines Article P4-ATPase translocates lipids from the exoplasmic to the cytosolic plasma membrane leaflet to maintain lipid asymmetry distribution in eukaryotic cells. P4-ATPase is associated with severe neurodegenerative and metabolic diseases such as neurological and motor disorders. Thus, it is important to understand its transport mechanism. However, even with progress in X-ray diffraction and cryo-electron microscopy techniques, it is difficult to obtain the dynamic information of the phospholipid transport process in detail. There are still some problems required to be resolved: (1) when does the lipid transport happen? (2) How do the key residues on the transmembrane helices contribute to the free energy of important states? In this work, we explore the phospholipid transport mechanism using a coarse-grained model and binding free energy calculations. We obtained the free energy landscape by coupling the protein conformational changes and the phospholipid transport event, taking ATP8A1-CDC50 (the typical subtype of P4-ATPase) as the research object. According to the results, we found that the phospholipid would bind to the ATP8A1-CDC50 at the early stage when ATP8A1-CDC50 changes from E2P to E2Pi-PL state. We also found that the electrostatic effects play crucial roles in the phospholipid transport process. The information obtained from this work could help us in designing novel drugs for P-type flippase disorders. MDPI 2023-02-13 /pmc/articles/PMC9953615/ /pubmed/36831082 http://dx.doi.org/10.3390/biomedicines11020546 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zhang, Honghui
Zhang, Yue
Xu, Peiyi
Bai, Chen
Exploring the Phospholipid Transport Mechanism of ATP8A1-CDC50
title Exploring the Phospholipid Transport Mechanism of ATP8A1-CDC50
title_full Exploring the Phospholipid Transport Mechanism of ATP8A1-CDC50
title_fullStr Exploring the Phospholipid Transport Mechanism of ATP8A1-CDC50
title_full_unstemmed Exploring the Phospholipid Transport Mechanism of ATP8A1-CDC50
title_short Exploring the Phospholipid Transport Mechanism of ATP8A1-CDC50
title_sort exploring the phospholipid transport mechanism of atp8a1-cdc50
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953615/
https://www.ncbi.nlm.nih.gov/pubmed/36831082
http://dx.doi.org/10.3390/biomedicines11020546
work_keys_str_mv AT zhanghonghui exploringthephospholipidtransportmechanismofatp8a1cdc50
AT zhangyue exploringthephospholipidtransportmechanismofatp8a1cdc50
AT xupeiyi exploringthephospholipidtransportmechanismofatp8a1cdc50
AT baichen exploringthephospholipidtransportmechanismofatp8a1cdc50